Thalassemia

Thalassemia is a genetic blood disorder that decreases the development of  haemoglobin It leads to a lack of red blood cells and low oxygen levels. this induces a loss of  red blood cells and low blood oxygen levels, leading to a variety of health issues.  Thalassemia, alpha-thalassemia and beta-thalassemia are two main types. Symptoms and signs may vary but may include mild anaemia, malignancy, tiredness, yellow skin discolouration (jaundice), and bone problems. Beta thalassemia is caused by changes (mutations) in the HBB gene while alpha thalassemia is caused by mutations in the genes HBA1 and HBA2. Both are inherited in an autosomal receive manner. Treatment depends on the type and severity of the condition but may include blood transfusions and or supplements of folic acid.

 

  • Genetic mutations
  • Splenomegaly
  • Cooleys anemia
  • Hepatomegaly

Related Conference of Thalassemia

September 21-22, 2020

14th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 19-20, 2020

24th European Biotechnology Congress (EBC_2020)

London, UK
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Thalassemia Conference Speakers

Recommended Sessions

Related Journals

Are you interested in